Recent Finacing
Recent Raise
Ab Initio is an immuno-oncology biotech from J&J’s Bay Area incubator that develops a GPCR antibody discovery platform to engineer and discover GPCR-activating therapeutic antibodies in pharma collaborations.
Focus Areas
Recent Investors
Funding round
Investor